Tony Mok: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Mok, Tony S K, Wu, Yi-Long, Kudaba, Iveta, Kowalski, Dariusz M, Cho, Byoung Chul, Turna, Hande Z, Castro, Gilberto, Srimuninnimit, Vichien, Laktionov, Konstantin K, Bondarenko, Igor, Kubota, Karou, Lu

Journal:

Lancet (London, England)

Year:

2019

Language:

english

File:

PDF, 1.18 MB

english, 2019

2

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions

Soo, Ross A., Lim, Sun Min, Syn, Nicholas L., Teng, Rebecca, Soong, Richie, Mok, Tony S.K., Cho, Byoung Chul

Journal:

Year:

2018

Language:

english

File:

PDF, 810 KB

english, 2018

3

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Mok, Tony S., Wu, Yi-Long, Thongprasert, Sumitra, Yang, Chih-Hsin, Chu, Da-Tong, Saijo, Nagahiro, Sunpaweravong, Patrapim, Han, Baohui, Margono, Benjamin, Ichinose, Yukito, Nishiwaki, Yutaka, Ohe, Yui

Journal:

Boston Medical and Surgical Journal

Year:

2009

Language:

english

File:

PDF, 460 KB

english, 2009

4

De-novo and acquired resistance to immune checkpoint targeting

Syn, Nicholas L, Teng, Michele W L, Mok, Tony S K, Soo, Ross A

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 534 KB

english, 2017

5

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

Camidge, D. Ross, Dziadziuszko, Rafal, Peters, Solange, Mok, Tony, Noe, Johannes, Nowicka, Malgorzata, Gadgeel, Shirish M., Cheema, Parneet, Pavlakis, Nick, de Marinis, Filippo, Cho, Byoung Chul, Zhan

Journal:

Journal of Thoracic Oncology

Year:

2019

Language:

english

File:

PDF, 506 KB

english, 2019

6

Dacomitinib in NSCLC: a positive trial with little clinical impact – Authors' reply

Wu, Yi-Long, Mok, Tony S

Journal:

The Lancet Oncology

Year:

2018

Language:

english

File:

PDF, 33 KB

english, 2018

7

Personalized medicine in lung cancer: what we need to know

Mok, Tony S. K.

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2011

Language:

english

File:

PDF, 280 KB

english, 2011

8

First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer

Solomon, Benjamin J., Mok, Tony, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Iyer, Shrividya, Reisman, Arlen

Journal:

New England Journal of Medicine

Year:

2014

Language:

english

File:

PDF, 619 KB

english, 2014

9

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

Park, Keunchil, Tan, Eng-Huat, O'Byrne, Ken, Zhang, Li, Boyer, Michael, Mok, Tony, Hirsh, Vera, Yang, James Chih-Hsin, Lee, Ki Hyeong, Lu, Shun, Shi, Yuankai, Kim, Sang-We, Laskin, Janessa, Kim, Dong-

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 524 KB

english, 2016

10

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Rolfo, Christian, Mack, Philip C., Scagliotti, Giorgio V., Baas, Paul, Barlesi, Fabrice, Bivona, Trever G., Herbst, Roy S., Mok, Tony S., Peled, Nir, Pirker, Robert, Raez, Luis E., Reck, Martin, Riess

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 679 KB

english, 2018

11

Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

Shaw, Alice T, Kim, Tae Min, Crinò, Lucio, Gridelli, Cesare, Kiura, Katsuyuki, Liu, Geoffrey, Novello, Silvia, Bearz, Alessandra, Gautschi, Oliver, Mok, Tony, Nishio, Makoto, Scagliotti, Giorgio, Spig

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 652 KB

english, 2017

12

Is the LENT Score Already Outdated?

Rozman, Ales, Mok, Tony S.K.

Journal:

Year:

2018

Language:

english

File:

PDF, 41 KB

english, 2018

13

Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain

Yoon, Do Heum, Bin, Seong-Il, Chan, Simon Kin-Cheong, Chung, Chun Kee, In, Yong, Kim, Hyoungmin, Lichauco, Juan Javier, Mok, Chi Chiu, Moon, Young-Wan, Ng, Tony Kwun-Tung, Penserga, Ester Gonzales, Sh

Journal:

BMC Musculoskeletal Disorders

Year:

2017

Language:

english

File:

PDF, 575 KB

english, 2017

14

Quantifying the benefit of non-small-cell lung cancer immunotherapy – Authors' reply

Mok, Tony S K, Zhang, Jin, Lopes, Gilberto

Journal:

Lancet (London, England)

Year:

2019

File:

PDF, 255 KB

2019

15

Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer

Mok, Tony S.K., Lam, Kwok Chi, Lee, Conrad, Zhang, Li, Wong, Herman, Chan, Anthony T.C., Yeo, Winnie, Yim, Anthony P.C., Chak, Karen, Zee, Benny

Journal:

Year:

2005

Language:

english

File:

PDF, 111 KB

english, 2005

16

Methodology for quality-of-life assessment: a critical appraisal

Chung-Ying Zee, Benny, Mok, Tony S.K.

Journal:

Thoracic Surgery Clinics

Year:

2004

Language:

english

File:

PDF, 202 KB

english, 2004

17

Non-small-cell lung cancer

Gridelli, Cesare, Rossi, Antonio, Carbone, David P., Guarize, Juliana, Karachaliou, Niki, Mok, Tony, Petrella, Francesco, Spaggiari, Lorenzo, Rosell, Rafael

Journal:

Nature Reviews Disease Primers

Year:

2015

Language:

english

File:

PDF, 3.14 MB

english, 2015

18

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

Alexa B. Turke, Kreshnik Zejnullahu, Yi-Long Wu, Youngchul Song, Dora Dias-Santagata, Eugene Lifshits, Luca Toschi, Andrew Rogers, Tony Mok, Lecia Sequist, Neal I. Lindeman, Carly Murphy, Sara Akhavan

Journal:

Year:

2010

Language:

english

File:

PDF, 1.51 MB

english, 2010

19

First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression

Schuler, Martin, Tan, Eng-Huat, O’Byrne, Kenneth, Zhang, Li, Boyer, Michael, Mok, Tony, Hirsh, Vera, Yang, James Chih-Hsin, Lee, Ki Hyeong, Lu, Shun, Shi, Yuankai, Kim, Sang-We, Laskin, Janessa, Kim,

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

2019

File:

PDF, 1.92 MB

2019

20

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

Wu, Yi-Long, Lu, Shun, Cheng, Ying, Zhou, Caicun, Wang, Jie, Mok, Tony, Zhang, Li, Tu, Hai-Yan, Wu, Lin, Feng, Jifeng, Zhang, Yiping, Luft, Alexander Valerievich, Zhou, Jianying, Ma, Zhiyong, Lu, You,

Journal:

Journal of Thoracic Oncology

Year:

2019

Language:

english

File:

PDF, 363 KB

english, 2019

21

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

Edward S Kim, Vera Hirsh, Tony Mok, Mark A Socinski, Radj Gervais, Yi-Long Wu, Long-Yun Li, Claire L Watkins, Mark V Sellers, Elizabeth S Lowe, Yan Sun, Mei-Lin Liao, Kell Østerlind, Martin Reck, Alis

Journal:

Year:

2008

Language:

english

File:

PDF, 243 KB

english, 2008

22

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial

Reck, Martin, Mok, Tony S K, Nishio, Makoto, Jotte, Robert M, Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Chri

Journal:

The Lancet Respiratory Medicine

Year:

2019

Language:

english

File:

PDF, 1.94 MB

english, 2019

23

Application of the international prognostic index in a study of chinese patients with non-hodgkin's lymphoma and a high incidence of primary extranodal lymphoma

Tony S. Mok, Joyce Steinberg, Anthony T. Chan, Winnie M. Yeo, P. Hui, Thomas W. Leung, Philip Johnson

Journal:

Year:

1998

Language:

english

File:

PDF, 193 KB

english, 1998

24

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma

Tony S. K. Mok, Benny Zee, Anthony T. C. Chan, Winnie Yeo, Wei Tse Yang, Anthony Yim, Sing Fai Leung, Binh Nguyen, Thomas W. T. Leung, Philip Johnson

Journal:

Year:

2000

Language:

english

File:

PDF, 95 KB

english, 2000

25

Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma

Tak W. Lee, George G. Chen, Hu Xu, Johnson H.Y. Yip, Ernest C.W. Chak, Tony S.K. Mok, Anthony P.C. Yim

Journal:

European Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 234 KB

english, 2003

26

Intercalated chemotherapy and erlotinib: a viable first-line option for patients with advanced NSCLC? – Authors' reply

Mok, Tony S K, Wu, Yi-Long

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 48 KB

english, 2013

27

Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer

Goto, Koichi, Ichinose, Yukito, Ohe, Yuichiro, Yamamoto, Nobuyuki, Negoro, Shunichi, Nishio, Kazuto, Itoh, Yohji, Jiang, Haiyi, Duffield, Emma, McCormack, Rose, Saijo, Nagahiro, Mok, Tony, Fukuoka, Ma

Journal:

Journal of Thoracic Oncology

Year:

2012

Language:

english

File:

PDF, 381 KB

english, 2012

28

Efficacy and Safety of Erlotinib in 1242 East/South-East Asian Patients with Advanced Non-small Cell Lung Cancer

Mok, Tony, Wu, Yi-long, Au, Joseph Siu-kie, Zhou, Caicun, Zhang, Li, Perng, Reury-Perng, Park, Keunchil

Journal:

Journal of Thoracic Oncology

Year:

2010

Language:

english

File:

PDF, 194 KB

english, 2010

29

Epigenetic Inactivation of the CpG Demethylase TET1 as a DNA Methylation Feedback Loop in Upper Aerodigestive Tract and Gastrointestinal Cancers

Li, Lili, Li, Chen, Mao, Haitao, Du, Zhenfang, Chan, Wai Yee, Murray, Paul, Luo, Bing, Tak-Cheung Chan, Anthony, Shu-Kam Mok, Tony, Ka-Leung Chan, Francis, Ambinder, Richard, Tao, Qian

Journal:

Clinical Gastroenterology and Hepatology

Year:

2017

Language:

english

File:

PDF, 114 KB

english, 2017

30

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Shukla, Navika D., Salahudeen, Ameen A., Taylor, Gregory A., Ramalingam, Suresh S., Vokes, Everett E., Goss, Glenwood D., Decker, Roy H., Kelly, Karen, Scagliotti, Giorgio V., Mok, Tony S., Wakelee, H

Journal:

Clinical Lung Cancer

Year:

2018

Language:

english

File:

PDF, 423 KB

english, 2018

31

Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status

An, She-Juan, Chen, Zhi-Hong, Su, Jian, Zhang, Xu-Chao, Zhong, Wen-Zhao, Yang, Jin-Ji, Zhou, Qing, Yang, Xue-Ning, Huang, Ling, Guan, Ji-Lin, Nie, Qiang, Yan, Hong-Hong, Mok, Tony S., Wu, Yi-Long, You

Journal:

Year:

2012

Language:

english

File:

PDF, 312 KB

english, 2012

32

Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer

Loong, Herbert H., Kwan, Sui-chun Sampson, Mok, Tony Shu-kam, Lau, Yat-ming

Journal:

Current Treatment Options in Oncology

Year:

2018

Language:

english

File:

PDF, 1.01 MB

english, 2018

33

Evolutionary drug scheduling models with different toxicity metabolism in cancer chemotherapy

Yong Liang, Kwong-Sak Leung, Tony Shu Kam Mok

Journal:

Applied Soft Computing

Year:

2008

Language:

english

File:

PDF, 485 KB

english, 2008

34

Spectral karyotyping indicates complex rearrangements in lung adenocarcinoma of nonsmokers

Shirley Ming-Hui Sy, Boli Fan, Tak-Wai Lee, Tony S.-K. Mok, Elizabeth Pang, Anthony Yim, Nathalie Wong

Journal:

Cancer Genetics and Cytogenetics

Year:

2004

Language:

english

File:

PDF, 190 KB

english, 2004

35

P1.34: First-Line Afatinib vs Gefitinib for Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: The LUX-Lung 7 Trial

Aix, Santiago Ponce, Park, Keunchil, Tan, Eng-Huat, O’Byrne, Kenneth, Zhang, Li, Boyer, Michael, Mok, Tony, Hirsh, Vera, Chih-Hsin Yang, James, Märten, Angela, Paz-Ares, Luis

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 97 KB

english, 2016

36

P1.45: Impact of Dose Adjustment on Afatinib Safety and Efficacy in EGFR Mutation-Positive NSCLC: Post-Hoc Analyses of LUX-Lung 3/6

Barrios, Carlos H., Wu, Yi-Long, Chih-Hsin Yang, James, Sequist, Lecia V., Geater, Sarayut L., Mok, Tony, Hu, Cheng-Ping, Yamamoto, Nobuyuki, O’Byrne, Kenneth, Lu, Shun, Hirsh, Vera, Sebastian, Martin

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 97 KB

english, 2016

37

A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma

Chan, Stephen L., Yeo, Winnie, Mo, Frankie, Chan, Anthony W.H., Koh, Jane, Li, Leung, Hui, Edwin P., Chong, Charing C.N., Lai, Paul B.S, Mok, Tony S.K., Yu, Simon C.H.

Journal:

Year:

2017

Language:

english

File:

PDF, 384 KB

english, 2017

38

Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells

Leal Rojas, Ingrid M., Mok, Wai-Hong, Pearson, Frances E., Minoda, Yoshihito, Kenna, Tony J., Barnard, Ross T., Radford, Kristen J.

Journal:

Frontiers in Immunology

Year:

2017

Language:

english

File:

PDF, 2.06 MB

english, 2017

39

Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses

Mok, Tony S.K., Kim, Sang-We, Wu, Yi-Long, Nakagawa, Kazuhiko, Yang, Jin-Ji, Ahn, Myung-Ju, Wang, Jie, Yang, James Chih-Hsin, Lu, You, Atagi, Shinji, Ponce, Santiago, Shi, Xiaojin, Rukazenkov, Yuri, H

Journal:

Journal of Clinical Oncology

Year:

2017

File:

PDF, 823 KB

2017

40

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma

George P. Kim, Michelle R. Mahoney, Daniel Szydlo, Tony S. K. Mok, Robert Marshke, Kyle Holen, Joel Picus, Michael Boyer, Henry C. Pitot, Joseph Rubin, Philip A. Philip, Anna Nowak, John J. Wright, Ch

Journal:

Investigational New Drugs

Year:

2012

Language:

english

File:

PDF, 237 KB

english, 2012

41

Unresectable Hepatocellular Carcinoma: Randomized Controlled Trial of Transarterial Ethanol Ablation versus Transcatheter Arterial Chemoembolization

Yu, Simon Chun Ho, Hui, Joyce Wai Yi, Hui, Edwin Pun, Chan, Stephen Lam, Lee, Kit Fai, Mo, Frankie, Wong, John, Ma, Brigette, Lai, Paul, Mok, Tony, Yeo, Winnie

Journal:

Year:

2014

Language:

english

File:

PDF, 1.06 MB

english, 2014

42

P3.02c-038 First-Line Atezolizumab plus Chemotherapy in Chemotherapy-Naïve Patients with Advanced NSCLC: A Phase III Clinical Program

Cappuzzo, Frederico, Reck, Martin, Papadimitrakopoulou, Vassiliki, Jotte, Robert, West, Howard, Mok, Tony, Sandler, Alan, Mocci, Simonetta, Coleman, Shelley, Asakawa, Takashi, Socinski, Mark

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 146 KB

english, 2017

43

A review of regimens combining pemetrexed with an epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of advanced nonsquamous non-small cell lung cancer

Yang, James Chih-Hsin, Mok, Tony, Han, Baohui, Orlando, Mauro, Puri, Tarun, Park, Keunchil

Journal:

Clinical Lung Cancer

Year:

2017

Language:

english

File:

PDF, 854 KB

english, 2017

44

Phase II Trial of Gemcitabine-Carboplatin-Paclitaxel as Neoadjuvant Chemotherapy for Operable Non-small Cell Lung Cancer

Abratt, Raymond P., Lee, Jung Sin, Han, Ji Youn, Tsai, Chun-Ming, Boyer, Michael, Mok, Tony, Kim, Sang-We, Lee, Jin Soo, Brnabic, Alan J.M., Reece, William H.H., Lehnert, Manfred

Journal:

Journal of Thoracic Oncology

Year:

2006

Language:

english

File:

PDF, 154 KB

english, 2006

45

Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non–Small-cell Lung Cancer in Asia

Loong, Herbert H., Raymond, Victoria M., Shiotsu, Yukimasa, Chua, Daniel T.T., Teo, Peter M.L., Yung, Tony, Skrzypczak, Stan, Lanman, Richard B., Mok, Tony S.K.

Journal:

Clinical Lung Cancer

Year:

2018

Language:

english

File:

PDF, 1.30 MB

english, 2018

46

Anticancer therapy and lung injury: molecular mechanisms

Li, Li, Mok, Henry, Jhaveri, Pavan, Bonnen, Mark D, Sikora, Andrew G, Eissa, N. Tony, Komaki, Ritsuko U, Ghebre, Yohannes T

Journal:

Expert Review of Anticancer Therapy

Year:

2018

Language:

english

File:

PDF, 962 KB

english, 2018

47

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

Yeo, Winnie, Steinberg, Joyce L., Tam, John S., Chan, Paul K.S., Leung, Nancy W.Y., Lam, Kwok C., Mok, Tony S.K., Johnson, Philip J.

Journal:

Journal of Medical Virology

Year:

1999

Language:

english

File:

PDF, 76 KB

english, 1999

48

Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy

Winnie Yeo, Frankie K. F. Mo, Stephen L. Chan, Nancy W. Y. Leung, Pun Hui, Wai-Yip Lam, Tony S. K. Mok, Kowk C. Lam, Wing M. Ho, Jane Koh, Julian W. Tang, Anthony T. Chan, Paul K. S. Chan

Journal:

Year:

2007

Language:

english

File:

PDF, 209 KB

english, 2007

49

The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with Gefitinib

Qiang Nie, Zhen Wang, Guo-chun Zhang, She-juan An, Jia-yin Lin, Ai-lin Guo, Rong Li, Bin Gan, Ying Huang, Tony S. Mok, Yi-long Wu

Journal:

European Journal of Pharmacology

Year:

2007

Language:

english

File:

PDF, 255 KB

english, 2007

50

Increased thromboxane B2 levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma

George G. Chen, Tak W. Lee, Johnson H.Y. Yip, Hu Xu, Isa K.Y. Lee, Tony S.K. Mok, Timothy D. Warner, Anthony P.C. Yim

Journal:

Year:

2006

Language:

english

File:

PDF, 150 KB

english, 2006

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски